Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.